Anipamil
- Level
- Commodity
- Parent
- 51431600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51431601This classification denotes a calcium channel blocker, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9Y54WZV1CJ. European Medicines Agency schedules Anipamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05516MIG. Anipamil generally arises in the molecular formula C34H52N2O2. The term ANIPAMIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) ANIPAMIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule anipamil under HS 29269095 and SITC 51484. As of Q4 2014, ANIPAMIL remains the US FDA Preferred Term for this commodity. Anipamil bears US NLM identifiers UMLS ID C0051916 and NCI Concept Code C76578. SMILES: O(c1cc(C(CCCCCCCCCCCC)(CCCN(CCc2cc(OC)ccc2)C)C#N)ccc1)C.
Same parent
Under 51431600 · 14Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.